A worker is seen at the manufacturing workshop of vaccine maker Wuhan Institute of Biological Products in Wuhan, Hubei province, China May 26, 2010. Picture taken May 26, 2010. REUTERS/Stringer ATTENTION EDITORS - THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT.
Epidemics are bad business for pharmaceutical companies; stopping them is risky and expensive. After factoring in regulatory approvals, it can take years to put a drug on the market - often after an outbreak has burned out. Merck’s Ebola vaccine, for example, was only approved by the U.S. authorities in December, more than five years after the disease peaked in West Africa. And even if treatment is developed in time, politicians tend to lean on producers to keep prices low.
Progress on the coronavirus sounds encouraging. A handful claim they can have a vaccine ready for clinical testing in as little as 90 days; it took roughly 20 months to start testing during the 2003 SARS epidemic.
Breakingviews mak_robyn RNA vaccines could be game changing. I hope they come to fruition.
Breakingviews mak_robyn Reuter’s must help those who dare speak out about Wuhan true state.
Breakingviews mak_robyn I love a good Darwinian, Natural Selection story.
Breakingviews mak_robyn That’s what lab created viruses are for